Ian Tracy

618 total citations
9 papers, 191 citations indexed

About

Ian Tracy is a scholar working on Immunology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Ian Tracy has authored 9 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Ian Tracy's work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Ian Tracy is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). Ian Tracy collaborates with scholars based in United Kingdom, Germany and United States. Ian Tracy's co-authors include Francesco Forconi, Andrew J. Steele, Graham Packham, Annalisa D’Avola, Freda K. Stevenson, Peter Johnson, Martin J. Glennie, Lekh N. Dahal, Diego Gómez‐Nicola and Lang Dou and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Ian Tracy

9 papers receiving 190 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian Tracy United Kingdom	6	99	98	76	58	36	9	191
Stefano Vergani United States	9	125 1.3×	55 0.6×	32 0.4×	59 1.0×	38 1.1×	19	202
Marina Motta Italy	9	126 1.3×	145 1.5×	88 1.2×	63 1.1×	64 1.8×	25	264
Giorgia Chiodin United Kingdom	7	67 0.7×	156 1.6×	81 1.1×	74 1.3×	36 1.0×	14	203
Laura Jacobus United States	5	182 1.8×	45 0.5×	58 0.8×	39 0.7×	96 2.7×	10	260
Maria Gounari Greece	7	150 1.5×	233 2.4×	174 2.3×	51 0.9×	23 0.6×	14	271
Tomáš Reigl Czechia	7	70 0.7×	105 1.1×	134 1.8×	39 0.7×	77 2.1×	10	233
Marie-Laure Golinski France	8	97 1.0×	49 0.5×	96 1.3×	40 0.7×	12 0.3×	18	234
Silvia Imbergamo Italy	10	60 0.6×	119 1.2×	62 0.8×	54 0.9×	44 1.2×	20	224
Mia Thorsélius Sweden	6	109 1.1×	230 2.3×	206 2.7×	45 0.8×	65 1.8×	8	268
Mark-David Levin Netherlands	3	50 0.5×	82 0.8×	69 0.9×	27 0.5×	44 1.2×	4	127

Countries citing papers authored by Ian Tracy

Since Specialization

Citations

This map shows the geographic impact of Ian Tracy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Tracy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Tracy more than expected).

Fields of papers citing papers by Ian Tracy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Tracy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Tracy. The network helps show where Ian Tracy may publish in the future.

Co-authorship network of co-authors of Ian Tracy

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Tracy. A scholar is included among the top collaborators of Ian Tracy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Tracy. Ian Tracy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Tracy, Ian, Maria Fernanda Setúbal Destro Rodrigues, Michael Smith, et al.. (2025). Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response. Molecular Cancer. 24(1). 3–3. 16 indexed citations

O’Brien, Eleanor M., Ian Tracy, Joanna Selfe, et al.. (2023). Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells. Clinical Epigenetics. 15(1). 167–167. 5 indexed citations

Tracy, Ian, et al.. (2021). Targeting EZH2 for the treatment of soft tissue sarcomas. Journal of Cancer Metastasis and Treatment. 5 indexed citations

Chiodin, Giorgia, Annalisa D’Avola, Ian Tracy, et al.. (2018). Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients. Clinical Cancer Research. 25(8). 2503–2512. 19 indexed citations

Dahal, Lekh N., Lang Dou, Khiyam Hussain, et al.. (2017). STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy. Cancer Research. 77(13). 3619–3631. 59 indexed citations

D’Avola, Annalisa, Ian Tracy, Laura Chiecchio, et al.. (2016). Surface IgM expression and function are associated with clinical behavior, genetic abnormalities, and DNA methylation in CLL. Blood. 128(6). 816–826. 42 indexed citations

Gardiner, Anne, Helen Parker, Sharron Glide, et al.. (2011). A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia. Leukemia Research. 36(3). 307–310. 9 indexed citations

Pepper, Chris, Aneela Majid, Thet Thet Lin, et al.. (2011). Defining the prognosis of early stage chronic lymphocytic leukaemia patients. British Journal of Haematology. 156(4). 499–507. 33 indexed citations

Zenz, Thorsten, Martin Trbušek, Axel Benner, et al.. (2008). TP53 Abnormalities in Chronic Lymphocytic Leukemia Exhibit a Disease Specific Profile: Meta-Analysis of 270 Mutations.. Blood. 112(11). 2077–2077. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact